ND Committee Review
Internal Medical Policy Committee 1-22-2020 Annual Review
Internal Medical Policy Committee 4-6-2020
- Added COVID-19 diagnosis codes for coverage; and
- Removed procedure codes J7639; J7682; and J7685; and
- Created new policy Inhalation Products for the Management of Cystic Fibrosis; and
- Added diagnosis codes E84.11; E84.19; E84.8; and E84.9.
Internal Medical Policy Committee 1-19-2021 Coding update
- Added diagnosis code J12.82
Internal Medical Policy Committee 5-20-2021 Revision
- Removed the medication Isoetharine.
Internal Medical Policy Committee 5-24-2022 Annual Review-no changes in criteria.
Internal Medical Policy Committee 7-21-2022 Revision- Effective September 05, 2022
- Added clarifying statements
- Added diagnosis code: Z93.0
Internal Medical Policy Committee 11-15-2023 Coding- Effective October 1, 2023
- Added diagnosis codes: J15.61; J15.69; and J44.89 to procedure codes A4619; A7003; A7004; A7005; A7013; A7014; A7015; A7525; E0570; J3490; J7605; J7606; J7608; J7611; J7612; J7613; J7614; J7626; J7631; J7644; J7669; S0142; A4619; A7010; A7012; A7013; A7014; A7015; A7017; A7525; A7526; E0565; E0572; E0585; E1372; and
- Removed diagnosis code : J15.6; from procedure codes A4619; A7003; A7004; A7005; A7013; A7014; A7015; A7525; E0570; J3490; J7605, J7606, J7608; J7611; J7612; J7613; J7614; J7626; J7631; J7644; J7669; S0142; A4619; A7010; A7012; A7013; A7014; A7015; A7017; A7525; A7526; E0565; E0572; E0585; and E1372.
Internal Medical Policy Committee 3-19-2024 Coding update- Effective May 06, 2024
- Added diagnosis codes J20.0; J20.1; J20.2; J20.3; J20.4; J20.4, J20.5; J20.6; J20.7; J20.9; J21.0; J21.1; J21.8; J21.9; J80; R05.1; R06.02; & R06.2; for procedure codes A7003; J7613 and E0570; and
- Added Policy Application